ARCHIVES

Perjeta Neoadjuvant Therapy Granted Accelerated Approval In HER2 Breast Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Personal letters: mixed reviews of Donald Pinkel’s article on Childhood Lymphocytic Leukemia

May 6, 2021

DCPC Bard Approves Concepts For New Minority Enhancement Awards Program, Two RFA Reissues

January 22, 1988

Basic Research Group Seeks $7.9 Billion For NIH, $1.7 For NCI

July 24, 1987

ACS Elects New Volunteer Leaders

November 19, 2010

Hellman, Suit Awarded ASTRO’s Gold Medals

October 26, 1990

DCE Board Approves Epidemiology Contract Recompetitions

March 17, 1995